Peptide hormones: Review of current and emerging uses by nasal delivery
- 1 January 1998
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 29 (1-2) , 81-87
- https://doi.org/10.1016/s0169-409x(97)00062-8
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- A 35 amino acid fragment of leptin inhibits feeding in the ratEndocrinology, 1996
- Intranasal administration of the GHRP hexarelin accelerates growth in short childrenClinical Endocrinology, 1995
- Diagnostic studies with intravenous and intranasal growth hormone- releasing peptide-2 in children of short statureJournal of Clinical Endocrinology & Metabolism, 1995
- Growth hormone releasing activity by intranasal administration of a synthetic hexapeptide (hexarelin)Clinical Endocrinology, 1994
- Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in manJournal of Clinical Endocrinology & Metabolism, 1994
- Peritoneal and subcutaneous absorption of insulin in type I diabetic subjectsJournal of Clinical Endocrinology & Metabolism, 1993
- Intranasal administration of growth hormone‐releasing hormone(1–29)‐NH2 in children with growth hormone deficiency: effects on growth hormone secretion and growthActa Paediatrica, 1993
- Pharmacokinetics of growth hormone‐releasing hormone(1–29)‐NH2 and stimulation of growth hormone secretion in healthy subjects after intravenous or intranasal administrationActa Paediatrica, 1993
- A randomized comparison of intranasal and injectable octreotide administration in patients with acromegalyJournal of Clinical Endocrinology & Metabolism, 1992
- Intranasal Drug DeliveryClinical Pharmacokinetics, 1989